Winning studies were chosen by members of the Clinical Research Forum, a nonprofit foundation that promotes the understanding of clinical research and its impact on health and health care.

Researchers used electroencephalography and artificial intelligence to identify individuals who would likely respond to sertraline, the antidepressant marketed as Zoloft.

Making inclusion work, particularly at the institutional level, is the challenge, speakers asserted.

Stanford Children’s Health experts are applying CDC funding and design thinking toward making their weight-management program available to low-income families nationwide.

Indoor-tanning studies with financial ties to the industry are likely to downplay risks and discuss the potential benefits of tanning, researchers have found.

The longtime assistant dean for minority affairs has retired after decades of recruiting students from under-represented groups to Stanford School of Medicine.

A new study asserts that disease-management clinics, home visits by nurses and nurse case management should become the standard of care for elderly patients with heart failure after they are discharged from the hospital.

Stanford researchers have found that drug-coated nanoparticles limit the development of atherosclerosis in mice, without side effects.

Stanford data scientists have shown that figuring out a single number can help them find the most dangerous cancer cells.

An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.